20/20 launches its new L-IHC lab services July 1, 2010 using its proprietary multilayer IHC platform for the development of new companion diagnostics.
20/20 launches its new L-IHC lab services. Beginning July 1, 20/20 will begin using its proprietary multilayer IHC platform for the development of new companion diagnostics. Services will be preformed in 20/20′s Rockville MD laboratory under the direction of Michael Leibowitz Phd. New customized studies will be developed and run for leading cancer research centers and developers of targeted cancer therapies.